Bullish
Deutsche Bank has aggressively upgraded Humana (NYSE:HUM) to Buy, nearly doubling its price target to $441 from $235, signaling a fundamental reset an...
Deutsche Bank has upgraded Humana (HUM) to a "Buy" rating from "Hold" and significantly increased its price target to $441 from $235. This positive ad...
Neutral
The North Dakota State Investment Board has initiated a new position in Humana Inc. (NYSE:HUM) by acquiring 5,922 shares valued at approximately $1.52...
Neutral
Humana Inc. remains a key player in the US Medicare Advantage market, with its recent Q1 2025 earnings and updated 2025 guidance highlighting the comp...
Neutral
Northwestern Mutual Wealth Management Co. significantly increased its stake in Humana Inc. (NYSE:HUM) by 10,277.6% in the fourth quarter, purchasing a...
Neutral
Zacks Research has upgraded Humana (NYSE:HUM) from a "strong sell" to a "hold" rating, despite trimming several of its earnings estimates for the comp...
Morgan Stanley has increased its price target for Humana (HUM) to $217 from $146, while maintaining an Underweight rating on the stock. This adjustmen...
/Humana%20Inc_%20logo%20on%20building-by%20BalkansCat%20via%20iStock.jpg)
Bullish
Humana Inc. (HUM) has outperformed the S&P 500 and the iShares U.S. Healthcare Providers ETF over the past year and year-to-date. The company recently...
Humana Inc.'s average price target has been increased to $246.46 by 24 analysts, with forecasts ranging from $180 to $290 per share. This updated targ...
Bullish
CVRx announced that Humana has issued a Medicare Advantage coverage policy for its Barostim therapy, effective May 1, 2026. This policy marks a signif...
Humana, CenterWell, and USAA are partnering with the Veterans of Foreign Wars (VFW) for a National Day of Service on May 19 to support veterans experi...
Neutral
Zacks Research has issued a "Strong Sell" rating for Humana (NYSE:HUM) and lowered its Q1 2027 EPS estimate for the company. Despite this negative out...
Neutral
Humana (Humana Inc.) recently reported higher revenue but weaker net income and a downward revision to its full-year GAAP EPS outlook, prompting reass...
Humana (HUM) is under scrutiny after its latest quarterly update, which included a reduced full-year GAAP diluted EPS outlook, despite higher revenue....
Bullish
Bernstein SocGen Group has increased its price target for Humana Inc. (NYSE:HUM) shares to $288 from $211, maintaining an Outperform rating. This adju...
Neutral
Bronstein, Gewirtz & Grossman, LLC has launched an investigation into potential corporate wrongdoing by Humana Inc. (NYSE:HUM). The firm encourages in...
Neutral
PFA Pension Forsikringsaktieselskab recently acquired a new stake in Humana Inc. (NYSE:HUM) during Q4, purchasing 34,792 shares valued at approximatel...
Neutral
Strs Ohio significantly increased its stake in Humana Inc. by 47.3% in the fourth quarter, acquiring an additional 16,506 shares. Multiple institution...
Neutral
Humana Inc. reported Q1 2026 revenue of US$39.648 billion and completed a US$276.13 million share repurchase, but simultaneously lowered its full-year...
Neutral
Comerica Bank has reduced its stake in Humana Inc. by selling 4,526 shares, bringing its total holding to 14,390 shares valued at $3.686 million. Desp...